PAA 0.00% 17.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-642

  1. 568 Posts.
    lightbulb Created with Sketch. 142
    Bucky I don't think those other treatments are dead in the water either. MT says terribly time consuming and expensive but doesn't negate the possibility of MPL being effective. K9 still in the background and K9 was always a precursor to human. As for Covid, I guess everyone has forgotten that global movement was at a standstill and no work could get done. Doesn't mean we don't have something which could be effective for it. It isn't going away any time soon and perhaps since the common cold is also a corona virus, there may be some there as well. Permanent income for some pharma.....noticed all the cold and flu tablets on the shelves?

    But for me, MND has a great benefit and study can be completed more quickly than the others so I say they are on the right path for the time being.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $85.12M
Open High Low Value Volume
18.0¢ 18.0¢ 17.0¢ $141.2K 801.7K

Buyers (Bids)

No. Vol. Price($)
11 537419 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 140000 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.